Abstract
Infectious disease caused by pathogenic bacteria continues to be the primary challenge to humanity. Antimicrobial resistance and microbial biofilm formation in part, lead to treatment failures. The formation of biofilms by nosocomial pathogens such as Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Klebsiella pneumoniae (K. pneumoniae) on medical devices and on the surfaces of infected sites bring additional hurdles to existing therapies. In this review, we discuss the challenges encountered by conventional treatment strategies in the clinic. We also provide updates on current on-going research related to the development of novel anti-biofilm technologies. We intend for this review to provide understanding to readers on the current problem in health-care settings and propose new ideas for new intervention strategies to reduce the burden related to microbial infections.
| Original language | English |
|---|---|
| Article number | 1705 |
| Number of pages | 27 |
| Journal | Materials |
| Volume | 11 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 13 Sept 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-biofilms
- Biofilms
- Klebsiella pneumoniae
- Nosocomial pathogens
- Pseudomonas aeruginosa
- Staphylococcus aureus
Fingerprint
Dive into the research topics of 'Targeting the Bacterial Protective Armour: Challenges and Novel Strategies in the Treatment of Microbial Biofilm'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver